|
|
|
Volumn 9, Issue 2, 1997, Pages 75-81
|
|
The clinical pharmacokinetics of macrolide immunosuppressants and its impact on the clinical management of organ transplantation;Die klinische pharmakokinetik von makrolidimmunsuppressiva und ihre bedeutung fur das klinische management nach organtransplantation
a
|
|
Author keywords
Cholestasis; Cytochrome P450; Drug metabolism; P glycoprotein; Sirolimus; Tacrolimus; Therapeutic drug monitoring
|
|
Indexed keywords
BROMOCRIPTINE;
CORTICOSTERONE;
CYCLOSPORIN;
CYTOCHROME P450;
DEXAMETHASONE;
ERGOTAMINE;
ERYTHROMYCIN;
ETHINYLESTRADIOL;
GLYCOPROTEIN P;
IMMUNOSUPPRESSIVE AGENT;
JOSAMYCIN;
KETOCONAZOLE;
MACROLIDE;
NIFEDIPINE;
OMEPRAZOLE;
PROGESTERONE;
RAPAMYCIN;
TACROLIMUS;
TROLEANDOMYCIN;
VERAPAMIL;
ANIMAL TISSUE;
CHOLESTASIS;
CLINICAL ARTICLE;
CLINICAL TRIAL;
COMPETITIVE INHIBITION;
DRUG ABSORPTION;
DRUG BIOAVAILABILITY;
DRUG ELIMINATION;
DRUG METABOLISM;
DRUG MONITORING;
ENZYME INHIBITION;
FEMALE;
GRAFT REJECTION;
HUMAN;
HUMAN TISSUE;
IMMUNOSUPPRESSIVE TREATMENT;
INTESTINE ABSORPTION;
LIVER METABOLISM;
LIVER TRANSPLANTATION;
MALE;
MICHAELIS MENTEN KINETICS;
NONHUMAN;
ORAL DRUG ADMINISTRATION;
ORGAN TRANSPLANTATION;
PHASE 3 CLINICAL TRIAL;
REVIEW;
|
|
EID: 0030862859
PISSN: 09469648
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (3)
|
|
References (54)
|
